[1]费正东, 彭爱琴, 崔红燕, 等. 声触诊组织定量技术鉴别脂肪肝背景下的肝脏良恶性结节[J]. 江苏大学学报(医学版), 2018, 28(4): 352-354, 361.
[2]Chan J, Alwahab Y, Tilley C, et al. Percutaneous medical liver core biopsies: correlation between tissue length and the number of portal tracts[J]. J Clin Pathol, 2010, 63(7): 655-656.
[3]Fryer E, Wang LM, Verrill C, et al. How often do our liver core biopsies reach current definitions of adequacy?[J]. J Clin Pathol, 2013, 66(12): 1087-1089.
[4]费正东, 彭爱琴, 谢卫峰, 等. 声触诊组织定量技术在肝硬化合并肝脏良恶性结节鉴别诊断中的价值[J]. 江苏大学学报(医学版), 2016, 26(3): 261-263.
[5]Neuberger J, Patel J, Caldwell H, et al. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology[J]. Gut, 2020, 69(8): 1382-1403.
[6]贾继东, 李兰娟. 慢性乙型肝炎防治指南(2010年版)[J]. 中华流行病学杂志, 2011, 32(4): 405-415.
[7]中华医学会传染病与寄生虫病学分会、 肝病学分会. 病毒性肝炎防治方案[J]. 中华肝脏病杂志, 2000, 8(6): 324-329.
[8]中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊断标准[J]. 中华肝脏病杂志, 2003, 11(2): 71.
[9]Schiano TD, Azeem S, Bodian CA, et al. Importance of specimen size in accurate needle liver biopsy evaluation of patients with chronic hepatitis C[J]. Clin Gastroenterol Hepatol, 2005, 3(9): 930-935.
[10]Khalifa A, Rockey DC. The utility of liver biopsy in 2020[J]. Curr Opin Gastroenterol, 2020, 36(3): 184-191.
[11]Cholongitas E, Quaglia A, Samonakis D, et al. Transjugular liver biopsy: how good is it for accurate histological interpretation?[J]. Gut, 2006, 55(12): 1789-1794.
[12]Rockey DC, Caldwell SH, Goodman ZD, et al. Liver biopsy[J]. Hepatology, 2009, 49(3): 1017-1044.
[13]Kleiner DE, Bedossa P. Liver histology and clinical trials for nonalcoholic steatohepatitisperspectives from 2 pathologists[J]. Gastroenterology, 2015, 149(6): 1305-1308.
[14]Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C[J]. Hepatology, 2003, 38(6): 1449-1457.
[15]Colloredo G, Guido M, Sonzogni A, et al. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease[J]. J Hepatol, 2003, 39(2): 239-244.
[16]Hall TC, Deakin C, Atwal GS, et al. Adequacy of percutaneous nontargeted liver biopsy under realtime ultrasound guidance when comparing the BiopinceTM and AchieveTM biopsy needle[J]. Br J Radiol, 2017, 90(1080): 20170397.
[17]Palmer T, Georgiades I, Treanor D, et al. Improved tissue sections for medical liver biopsies: a comparison of 16 vs 18 g biopsy needles using digital pathology[J]. J Clin Pathol, 2014, 67(5): 415-419.
|